FR2492662A1 - Composition pharmaceutique contenant de la d-biotine pour le traitement du diabete sucre - Google Patents

Composition pharmaceutique contenant de la d-biotine pour le traitement du diabete sucre Download PDF

Info

Publication number
FR2492662A1
FR2492662A1 FR8120147A FR8120147A FR2492662A1 FR 2492662 A1 FR2492662 A1 FR 2492662A1 FR 8120147 A FR8120147 A FR 8120147A FR 8120147 A FR8120147 A FR 8120147A FR 2492662 A1 FR2492662 A1 FR 2492662A1
Authority
FR
France
Prior art keywords
biotin
insulin
treatment
glucose
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8120147A
Other languages
English (en)
French (fr)
Other versions
FR2492662B1 (Direct
Inventor
John C Coggeshall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CAPITAL MEDICAL ASS
Original Assignee
CAPITAL MEDICAL ASS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CAPITAL MEDICAL ASS filed Critical CAPITAL MEDICAL ASS
Publication of FR2492662A1 publication Critical patent/FR2492662A1/fr
Application granted granted Critical
Publication of FR2492662B1 publication Critical patent/FR2492662B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR8120147A 1980-10-27 1981-10-27 Composition pharmaceutique contenant de la d-biotine pour le traitement du diabete sucre Granted FR2492662A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20078480A 1980-10-27 1980-10-27

Publications (2)

Publication Number Publication Date
FR2492662A1 true FR2492662A1 (fr) 1982-04-30
FR2492662B1 FR2492662B1 (Direct) 1985-04-19

Family

ID=22743169

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8120147A Granted FR2492662A1 (fr) 1980-10-27 1981-10-27 Composition pharmaceutique contenant de la d-biotine pour le traitement du diabete sucre

Country Status (6)

Country Link
JP (1) JPS5799520A (Direct)
AU (1) AU7683381A (Direct)
BE (1) BE890888A (Direct)
DE (1) DE3142590A1 (Direct)
FR (1) FR2492662A1 (Direct)
NL (1) NL8104818A (Direct)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE19855T1 (de) * 1982-03-01 1986-06-15 Efamol Ltd Pharmazeutische und diaetetische zusammensetzung.
CN1313030C (zh) * 2002-08-23 2007-05-02 帝斯曼知识产权资产管理有限公司 包含生物素的新颖的营养药物性组合物
JP2004203863A (ja) * 2002-12-09 2004-07-22 Taisho Pharmaceut Co Ltd 抗糖尿病用組成物
JP2006089392A (ja) * 2004-09-22 2006-04-06 Tohoku Univ 生活習慣病改善食品および生活習慣病治療薬

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154506A1 (en) * 1971-09-13 1973-05-11 Magnor Inc Medicaments contg biotin - as hypoglycaemic agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154506A1 (en) * 1971-09-13 1973-05-11 Magnor Inc Medicaments contg biotin - as hypoglycaemic agents

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARTIN NEGWER: ORGANISCH-CHEMISCHE ARZNEIMITTEL UND IHRE SYNONYMA, vol. I, 5ème édition, 1978, Akademie-Verlag, Berlin (DE) *

Also Published As

Publication number Publication date
NL8104818A (nl) 1982-05-17
DE3142590A1 (de) 1982-08-12
AU7683381A (en) 1982-05-06
JPS5799520A (en) 1982-06-21
BE890888A (fr) 1982-02-15
FR2492662B1 (Direct) 1985-04-19

Similar Documents

Publication Publication Date Title
EP2512236B1 (en) Improved method of administering beta-hydroxy-beta-methylbutyrate (hmb)
FR2629716A1 (fr) Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
KR101487852B1 (ko) 신규조성물 및 그 용도
NZ536889A (en) Use of pullulan as a slowly digested carbohydrate
JP2022523550A (ja) バイオアベイラビリティが改善した中鎖脂肪酸トリグリセリド製剤およびそれに関連する方法
Nakajima et al. Antihypertensive effect of extracts of Lactobacillus casei in patients with hypertension
EP3429611B1 (fr) Polycomplexes de composes poly-lysine pour la prevention et/ou la lutte contre la sclerose laterale amyotrophique
JP2010526858A (ja) 甲状腺ホルモンを含んでなる新たな医薬組成物及びその治療的使用
EP1526850B1 (fr) Utilisation de la vitamine C pour le traitement de la maladie de Charcot-Marie-Tooth
FR2492662A1 (fr) Composition pharmaceutique contenant de la d-biotine pour le traitement du diabete sucre
EP2274000B1 (fr) Composition pharmaceutique ou dietetique comprenant des extraits aqueux de nigella sativa et d'olea europea et/ou phyllantus amarus
CN116322659A (zh) 递送具有受控药物动力学、安全性和耐受性特性的中链甘油三酯的方法
CN116036290A (zh) 用于治疗皮肤病的联合疗法
EP3100737A1 (fr) Complément alimentaire comprenant un mélange d'oxyde de magnésium et de carbonate de magnésium
EP3046552A1 (fr) Composition intervenant dans la regulation du dysfonctionnement des cycles de l'energie, de l'inflammation et de l'insulinoresistance et son utilisation notamment dans les maladies cardiometaboliques
EP0306377A1 (fr) Nouvelles compositions d'éléments minéraux et/ou oligoéléments et leur procédé de préparation
Matsumura et al. Effects of changeover from voglibose to acarbose on postprandial triglycerides in type 2 diabetes mellitus patients
US6008253A (en) Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal
WO2015140747A1 (fr) Utilisation d'une composition vétérinaire à base de torasémide pour une administration à faible dose
US20250120425A1 (en) Combinations of Ketogenic Supplements for Rapid and Sustained Blood Ketone Levels in Dieters and Patients
FR3007986A1 (fr) Medicament destine a lutter contre l'infertilite et la sous-fertilite en particulier dans le cadre d'une sous fertilite ou infertilite metabolique
DE102006013624A1 (de) Mittel zur Anwendung bei Fructoseintoleranz
Kitada et al. Efficacy of SGLT2 inhibitor in type 2 diabetic patients under dietary instructions: A pilot study
RU2778848C2 (ru) Состав фенфлурамина, совместимый с кетогенной диетой
CN121313723A (zh) 一种具有降血糖功效的天然山茶油

Legal Events

Date Code Title Description
ST Notification of lapse